SILVER SPRING, Maryland (Reuters) - U.S. drug advisers backed Onyx Pharmaceuticals Inc's drug for patients who have failed to successfully treat their blood cancer with other medicines, making it ...
WASHINGTON (AP) — The Food and Drug Administration said Friday it approved a new blood cancer drug from Onyx Pharmaceuticals Inc. for patients with advanced disease who have not responded to at least ...
WASHINGTON (AP) - TheFood and Drug Administration is approving a new blood cancer drug fromOnyx Pharmaceuticals Inc. for patients whose disease has not responded to at least two other drugs. Krypolis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results